Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 1: MET, ROS1, and ALK
Why do we make a fuss about rare mutations in NSCLC? In 2015, they only made up about 1-2%...
Why do we make a fuss about rare mutations in NSCLC? In 2015, they only made up about 1-2%...
Hematological cancers were among the first to be discovered to have abnormal demethylation status. Excretion of epigenetic DNA modification...
The gut microbiome plays several key roles in human health.1 Gut microbes assist us with the absorption of some...